Literature DB >> 6354901

Surviving proportional hazards.

J D Elashoff.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6354901     DOI： 10.1002/hep.1840030623

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  9 in total

1.  Recurrence rate after highly selective vagotomy.

Authors:  D C Busman; A Volovics; J D Munting
Journal:  World J Surg       Date:  1988-04       Impact factor: 3.352

2.  Prognostic factors in survival after portasystemic shunts. Multivariate analysis.

Authors:  F Lacaine; G M LaMuraglia; R A Malt
Journal:  Ann Surg       Date:  1985-12       Impact factor: 12.969

3.  Multivariate analyses of factors associated with unemployment in people with multiple sclerosis.

Authors:  M Grønning; E Hannisdal; S I Mellgren
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-05       Impact factor: 10.154

4.  High energy neutron treatment for pelvic cancers: study stopped because of increased mortality.

Authors:  R D Errington; D Ashby; S M Gore; K R Abrams; S Myint; D E Bonnett; S W Blake; T E Saxton
Journal:  BMJ       Date:  1991-05-04

Review 5.  Review of survival analyses published in cancer journals.

Authors:  D G Altman; B L De Stavola; S B Love; K A Stepniewska
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

6.  Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency.

Authors:  Annyce S Mayer; James K Stoller; Sverre Vedal; A James Ruttenber; Matt Strand; Robert A Sandhaus; Lee S Newman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 7.  Compression for venous leg ulcers.

Authors:  Susan O'Meara; Nicky Cullum; E Andrea Nelson; Jo C Dumville
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

8.  Colony forming ability of human breast carcinomas: lack of prognostic significance.

Authors:  L Ottestad; K M Tveit; E Hannisdal; M Skrede; J M Nesland; S Gundersen; A Pihl
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

9.  Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centres.

Authors:  J Wagstaff; W M Gregory; R Swindell; D Crowther; T A Lister
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.